ADAR and chronic myelogenous leukemia, BCR-ABL1 positive: Moreover, ADAR1 activation drives leukemic stem cell (LSC) self‐renewal and its inhibition appeared as a good strategy to impair blast expansion in chronic myeloid leukemia (Jiang et al, 2013; Zipeto et al, 2016).